CAS 610309-89-2|Carvedilol phosphate
Introduction:Basic information about CAS 610309-89-2|Carvedilol phosphate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Carvedilol phosphate | ||
|---|---|---|---|
| CAS Number | 610309-89-2 | Molecular Weight | 513.48 |
| Density | / | Boiling Point | 655.2ºC at 760 mmHg |
| Molecular Formula | C24H26N2O4.H3PO4.1/2H2O | Melting Point | / |
| MSDS | / | Flash Point | 350.1ºC |
Names
| Name | 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,phosphoric acid,hydrate |
|---|---|
| Synonym | More Synonyms |
Carvedilol phosphate BiologicalActivity
| Description | Carvedilol is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation.IC50 Value: 3.8 μM ( inhibition of LDL oxidation)Target: beta Adrenergic ReceptorCarvedilol is a nonselective-blocking agent and is used in the treatment of hypertension and angina pectoris. As a third-generation β-adrenergic blocker (β-blocker), Carvedilol is able to reverse cardiac structural remodeling. Recentresults demonstrated that the effect caused by Carvedilol on cardiac remodeling is largely dependent on endogenous NO. |
|---|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Adrenergic ReceptorResearch Areas >>Cardiovascular Disease |
| References | [1]. Chen J, et al. The effects of carvedilol on cardiac structural remodeling: The role of endogenous nitric oxide in the activity of carvedilol. Mol Med Rep. 2013 Apr;7(4):1155-1158. [2]. Stafylas PC, et al. Carvedilol in hypertension treatment. Vasc Health Risk Manag. 2008;4(1):23-30. [3]. Othman AA, et al. Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate. AAPS J. 2007 Jun 15;9(2):E208-18. [4]. Koshimizu TA, et al. Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. Cardiovasc Res. 2004 Sep 1;63(4):662-672. |
Chemical & Physical Properties
| Boiling Point | 655.2ºC at 760 mmHg |
|---|---|
| Molecular Formula | C24H26N2O4.H3PO4.1/2H2O |
| Molecular Weight | 513.48 |
| Flash Point | 350.1ºC |
| PSA | 172.54000 |
| LogP | 3.13600 |
| InChIKey | LHNYXTULDSJZRB-UHFFFAOYSA-N |
| SMILES | COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O.O=P(O)(O)O.O=P(O)(O)O |
| Storage condition | -20℃ |
Synonyms
| 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-, phosphate, hydrate (2:2:1) (salt) |
| Carvedilol phosphate hydrate (JAN) |
| Carvedilol phosphate hemihydrate |
| Coreg CR (TN) |
| 1-(9H-Carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}-2-propanol phosphate hydrate (2:2:1) |
| Carvedilol phosphate |
| Carvedilol (phosphate hemihydrate) |
